NCT06771427 is a clinical trial of acupuncture GB20 or GB20 plus BL2 in Dry Eye Syndrome (DES), sponsored by Taipei Veterans General Hospital, Taiwan.

Who is sponsoring NCT06771427?

NCT06771427 is sponsored by Taipei Veterans General Hospital, Taiwan.

What drugs are being tested in NCT06771427?

Interventions in NCT06771427: acupuncture GB20 or GB20 plus BL2, Chinese herbal tea TBDESJS.

What condition does NCT06771427 study?

NCT06771427 studies Dry Eye Syndrome (DES), Sjogren's Syndrome, Xerophthalmia.

Is NCT06771427 still recruiting?

NCT06771427 is currently recruiting now. Last updated 17 January 2025.

Last reviewed 2025-01-17 · How we verify

NCT06771427

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

Recruiting now Last updated 17 January 2025

What this trial tests

trial testing acupuncture GB20 or GB20 plus BL2 in Dry Eye Syndrome (DES) in 220 participants. Currently enrolling.

Timeline

16 January 2025

Primary endpoint
30 April 2025

31 December 2026

Quick facts

Lead sponsor	Taipei Veterans General Hospital, Taiwan
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	220
Start date	16 January 2025
Primary completion	30 April 2025
Estimated completion	31 December 2026
Sites	1 location across Taiwan

Drugs / interventions tested

acupuncture GB20 or GB20 plus BL2
Chinese herbal tea TBDESJS — full drug profile →

Conditions studied

Dry Eye Syndrome (DES) — all drugs for Dry Eye Syndrome (DES) →
Sjogren's Syndrome — all drugs for Sjogren's Syndrome →
Xerophthalmia — all drugs for Xerophthalmia →

Sponsor

Taipei Veterans General Hospital, Taiwan

Who can join

Adults 20 to 75, any sex, with Dry Eye Syndrome (DES) or Sjogren's Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical applications of extracellular vesicles: recent advances and emerging trends.
Zou Y, Zhou Y, Li G, Dong Y, et al · · 2025 · cited 5× · PMID 41220804 · DOI 10.3389/fbioe.2025.1671963
The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases.
Li W, Li H, Fan L, Zhao R, et al · · 2025 · cited 1× · PMID 41127790 · DOI 10.2147/ijn.s547871
Extracellular Vesicles in Autoimmune Diseases: From Diagnostic Biomarkers to Engineered Therapeutics.
Wu Y, Ma H, Zhu T, Huang S, et al · · 2026 · PMID 41677384 · DOI 10.1002/advs.202521802

Verify or expand the search:

Other recruiting trials for Dry Eye Syndrome (DES)

Currently open trials in the same condition.

NCT06780293 — Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) · Phase 2 · recruiting

Other Taipei Veterans General Hospital, Taiwan trials

Trials by the same sponsor.

NCT07463443 — Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Stud · NA · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07362134 — Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter · NA · enrolling by invitation
NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT07344207 — GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06771427 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Veterans General Hospital, Taiwan
Last refreshed: 17 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06771427.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing